Latest Articles

Discover how cutting-edge tools and analytics are advancing cell therapy, improving precision, safety and scalability in modern treatments.

Learn how specific miRNA signatures have potential as metastatic colorectal cancer biomarkers, enhancing non-invasive detection and patient risk stratification.

For this article, Technology Networks asked a diverse group of academics and industry leaders: How should research funding change to better support innovation? Here’s how current models help – or hinder – their work.

Experts discuss how academic publishing must change to support open science, transparency and global accessibility in a digital-first research world.

This article explores the relationship between the immune system and cancer and outlines therapeutic strategies that leverage a patient’s immune system to treat cancer.

Could what's on your plate change your chemo outcome? Dietary microRNAs from food like eggs could affect cancer drug response – here’s what in silico analysis reveals about this promising discovery.

Technology Networks recently had the pleasure of interviewing Dr. Tyler Brown, founder, president and chair of OUTbio San Diego, to learn more about the organization’s origins, rapid growth and mission to create lasting impact.

Welcome to the second installment of "Cancer and the Gut Microbiome: A Miniseries". Here, we focus on how the microbiome influences the effectiveness of cancer treatments, particularly immunotherapy and chemotherapy.

This article explores how cancer biomarkers improve early detection, guide treatments and predict outcomes to transform personalized cancer care.

This article explores how next-generation sequencing has revolutionized microbiome research, enabling comprehensive analysis of microbial communities and their roles in health and disease.